Unknown OBSERVATIONAL NCT05292456

Monıtorıng Glucocortıcoıd Treatment In Patıents Followed In Rheumatology Clınıc

Monıtorıng Glucocortıcoıd Treatment Using Glucocorticoid Toxicity Index (GTI) In Patıents Followed In Rheumatology Clınıc

Sponsor: Hacettepe University

Conditions Glucocorticoids Toxicity Rheumatoid Arthritis Systemic Lupus Erythematosus Vasculitis

Updated 5 times since 2022 Last updated: Aug 1, 2022 Started: Feb 1, 2021 Primary completion: Aug 31, 2022 Completion: Dec 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Glucocorticoids Toxicity and Rheumatoid Arthritis and is currently ongoing. Hacettepe University leads this study, which shows 5 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Unknown
Sep 2024 — Sep 2025 [monthly]

Unknown

Status: Recruiting → Unknown
Jul 2024 — Sep 2024 [monthly]

Recruiting
Sep 2022 — Jul 2024 [monthly]

Recruiting
Apr 2022 — Sep 2022 [monthly]

Recruiting

First recorded

Feb 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hacettepe University

Data source: Hacettepe University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ankara, Turkey (Türkiye)